Oral Dosage Forms and Patient-Centric Design: An Overview

In the healthcare system, Pharmaceutical companies formulate medications into specific dosage forms to ensure accurate dosing, ease of use, and widespread patient acceptance. Oral dosage forms play a crucial role in treatment and wellness by delivering precise quantities of active pharmaceutical ingredients (APIs) efficiently and conveniently.

What are Oral Dosage Forms?

Oral dosage forms are pharmaceutical formulations designed for administration through the mouth, facilitating the delivery of APIs into the body. These forms remain widely used due to their convenience, stability, and high patient compliance.

Types of Oral Dosage Forms

  • Tablets: Compressed solid forms containing one or more APIs with excipients. They vary in shape, size, and release characteristics, including immediate-release, delayed-release, and extended-release formulations.
  • Capsules: Encapsulated powdered, granular, or liquid medication within gelatine shells. They mask unpleasant tastes and enable the delivery of combination therapies.
  • Powders and Granules: Finely divided solid dosage forms intended for internal use. Patients can be administered directly or dissolved in liquids for flexible dosing.
  • Liquids: Homogeneous liquid preparations, including solutions, emulsions, or suspensions of one or more active ingredients in a suitable liquid base.

The Evolution of Oral Dosage Forms

Historical Perspective on Oral Dosage Form Development

Since ancient times, civilizations have used oral medications, relying on herbal preparations. The Industrial Revolution introduced standardized tablet and capsule production, improving dosing precision and stability. Advances in formulation science have since led to modified-release dosage forms that enhance therapeutic control and patient adherence.

Advances in Tablet Excipients for Enhanced Drug Release

Modern medicines incorporate specialized ingredients to improve absorption, taste, and effectiveness. Innovations such as Osmotic Release Oral Systems (OROS) and multi-particulate drug delivery enhance therapeutic outcomes by ensuring drugs are released at the right time.

Innovations in Manufacturing Processes

Cutting-edge granulation techniques are revolutionizing oral dosage form production:

  • Reverse Wet Granulation: Enhances uniformity and drug distribution while reducing processing time.
  • Thermal Adhesion Granulation: Improves tablet mechanical properties without excessive moisture exposure.
  • Steam Granulation: Uses steam as a granulating agent, offering eco-friendly manufacturing benefits.

These advancements improve drug stability, uniformity, and performance, ensuring consistent therapeutic effects.

Principles of Patient-Centric Design in Oral Dosage Forms

Understanding Patient Needs for Medication Adherence

Patient adherence depends on factors such as ease of swallowing, taste, dosing frequency, and side effects. Paediatric, geriatric, and dysphagic patients often struggle with conventional tablets, making alternative formulations like Orally Disintegrating Tablets (ODT) and Oral Thin Films (OTF).

Incorporating Patient Feedback into Dosage Form Design

Pharmaceutical manufacturers actively collect patient insights to refine formulations for better acceptance and compliance. Sensory evaluations and real-world studies help ensure oral solid dosage forms align with patient preferences.

The Role of Sensory Attributes in Patient-Centric Formulations

Key factors influencing patient preference include:

  • Taste masking: Improves palatability for pediatric and geriatric populations.
  • Tablet/capsule size and shape: Facilitates easier swallowing.
  • Texture and mouthfeel: Reduces irritation or discomfort during administration.

By addressing these factors, pharmaceutical manufacturers enhance medication adherence and patient satisfaction.

Technological Innovations Enhancing Patient-Centricity

3D Printing for Personalised Oral Dosage Forms

3D printing technology enables precise customisation of oral dosage forms, allowing personalised dosing based on patient-specific factors such as age, weight, and medical condition. This approach particularly benefits paediatric and geriatric treatments requiring variable dosing.

Nanotechnology to Improve Drug Solubility and Absorption

Nanotechnology enhances drug dissolution, leading to faster and more efficient absorption, particularly for poorly water-soluble drugs. Nano-sized drug particles improve bioavailability and therapeutic efficacy.

Oral Thin Films for Monitoring Medication Adherence

Oral thin films (OTF) dissolve quickly in the mouth, providing rapid drug release and ensuring patient compliance. They offer an effective alternative to traditional tablets and capsules, especially for individuals with swallowing difficulties.

Challenges and Future Directions

Addressing the Needs of Diverse Patient Populations

Developing inclusive formulations that cater to different patient demographics remains challenging. Paediatric and geriatric populations benefit from alternative delivery systems such as liquid formulations, chewable tablets, and dispersible tablets.

Balancing Innovation with Cost-Effectiveness

While advanced drug delivery technologies improve patient health, affordability remains crucial for widespread accessibility. Pharmaceutical manufacturers must balance innovation with cost-effectiveness to maximise patient benefits.

Future Trends in Patient-Centric Oral Dosage Forms

  • Artificial Intelligence (AI) in Formulation Development: AI-driven models predict optimal formulations based on patient demographics.
  • Smart Pills with Digital Monitoring: Embedded microchips track medication adherence and transmit data to healthcare providers.
  • Sustainable Formulation Approaches: Environmentally friendly excipients and biodegradable packaging gain traction in pharmaceutical manufacturing.

Conclusion

Patient-centric design is transforming pharmaceutical development by making medications easier to take and more effective. When manufacturers prioritize patient needs, they enhance adherence and improve health outcomes.

ZIM Laboratories: Advancing Patient-Friendly Healthcare

ZIM Laboratories Limited is a therapy-agnostic and innovative drug delivery solution provider focusing on enhancing patient convenience and treatment adherence to medication. We offer a range of technology-based drug delivery solutions and non-infringing proprietary manufacturing processes to develop, manufacture, and supply innovative and differentiated generic Pharmaceutical and Nutraceutical products to our global customers. At ZIM Labs, we provide a comprehensive range of oral solid value-added, differentiated generic products in semi-finished and finished formulations. Our offerings include granules, pellets (with different release patterns like sustained, modified, extended-release, etc.), taste-masked powders, suspensions, tablets, capsules, and Oral Thin Films (OTF).

Subscribe

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.